Literature DB >> 23913989

A noncovalent, fluoroalkyl coating monomer for phosphonate-covered nanoparticles.

Vincent Li1, Andy Y Chang, Travis J Williams.   

Abstract

Gadolinium-containing phosphonate-coated gold nanoparticles were prepared and then non-covalently coated with an amphiphilic fluorous monomer. The monomer spontaneously self-assembles into a non-covalent monolayer shell around the particle. The binding of the shell utilizes a guanidinium-phosphonate interaction analogous to the one exploited by the Wender molecular transporter system. Particle-shell binding was characterized by a 27% decrease in 19F T1 of the fluorous shell upon exposure to the paramagnetic gadolinium in the particle and a corresponding increase in hydrodynamic diameter from 3 nm to 4 nm. Interestingly, a much smaller modulation of 19F T1 is observed when the shell monomer is treated with a phosphonate-free particle. By contrast, the phosphonate-free particle is a much more relaxive 1H T1 agent for water. Together, these observations show that the fluoroalkylguanidinium shell binds selectively to the phosphonate-covered particle. The system's relaxivity and selectivity give it potential for use in 19F based nanotheranostic agents.

Entities:  

Keywords:  Fluorine; Gold nanoparticle; Relaxivity; Surfaces; Theranostic

Year:  2013        PMID: 23913989      PMCID: PMC3728910          DOI: 10.1016/j.tet.2013.05.092

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  32 in total

Review 1.  Multimodal drug delivery using gold nanoparticles.

Authors:  Chae-kyu Kim; Partha Ghosh; Vincent M Rotello
Journal:  Nanoscale       Date:  2009-09-04       Impact factor: 7.790

2.  Paramagnetic relaxation-based 19f MRI probe to detect protease activity.

Authors:  Shin Mizukami; Rika Takikawa; Fuminori Sugihara; Yuichiro Hori; Hidehito Tochio; Markus Wälchli; Masahiro Shirakawa; Kazuya Kikuchi
Journal:  J Am Chem Soc       Date:  2007-12-23       Impact factor: 15.419

Review 3.  Gold revolution--gold nanoparticles for modern medicine and surgery.

Authors:  Radoslaw A Rippel; Alexander M Seifalian
Journal:  J Nanosci Nanotechnol       Date:  2011-05

Review 4.  Targeted nanotheranostics for personalized cancer therapy.

Authors:  Odile Diou; Nicolas Tsapis; Elias Fattal
Journal:  Expert Opin Drug Deliv       Date:  2012-10-23       Impact factor: 6.648

5.  Formation and NMR spectroscopy of ω-thiol protected α,ω-alkanedithiol-coated gold nanoparticles and their usage in molecular charge transport junctions.

Authors:  Andreas Wallner; S Hassan M Jafri; Tobias Blom; Adolf Gogoll; Klaus Leifer; Judith Baumgartner; Henrik Ottosson
Journal:  Langmuir       Date:  2011-06-23       Impact factor: 3.882

Review 6.  Gold nanoparticles for biology and medicine.

Authors:  David A Giljohann; Dwight S Seferos; Weston L Daniel; Matthew D Massich; Pinal C Patel; Chad A Mirkin
Journal:  Angew Chem Int Ed Engl       Date:  2010-04-26       Impact factor: 15.336

7.  The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice.

Authors:  Yasuyuki Akiyama; Takeshi Mori; Yoshiki Katayama; Takuro Niidome
Journal:  J Control Release       Date:  2009-06-16       Impact factor: 9.776

8.  Doxorubicin in sterically stabilized liposomes.

Authors:  D D Lasic
Journal:  Nature       Date:  1996-04-11       Impact factor: 49.962

9.  Gene transfer via reversible plasmid condensation with cysteine-flanked, internally spaced arginine-rich peptides.

Authors:  Zurab Siprashvili; Florence A Scholl; Steven F Oliver; Angie Adams; Christopher H Contag; Paul A Wender; Paul A Khavari
Journal:  Hum Gene Ther       Date:  2003-09-01       Impact factor: 5.695

10.  Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection.

Authors:  Jelena M Janjic; Mangala Srinivas; Deepak K K Kadayakkara; Eric T Ahrens
Journal:  J Am Chem Soc       Date:  2008-02-12       Impact factor: 15.419

View more
  2 in total

1.  A (Fluoroalkyl)Guanidine Modulates the Relaxivity of a Phosphonate-Containing T1-Shortening Contrast Agent.

Authors:  Xinping Wu; Anna C Dawsey; Buddhima N Siriwardena-Mahanama; Matthew J Allen; Travis J Williams
Journal:  J Fluor Chem       Date:  2014-12-01       Impact factor: 2.050

2.  Functionalized Gold Nanoparticles as Contrast Agents for Proton and Dual Proton/Fluorine MRI.

Authors:  Maria Şologan; Francesco Padelli; Isabella Giachetti; Domenico Aquino; Mariangela Boccalon; Gianpiero Adami; Paolo Pengo; Lucia Pasquato
Journal:  Nanomaterials (Basel)       Date:  2019-06-13       Impact factor: 5.076

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.